Citations

Showing 10 of 108094 citations.

Reduced Diffusing Capacity in Humidifier Disinfectant-Associated Asthma Versus Typical Asthma: A Retrospective Case Control Study
Pak, Chuiyong , Cowl, Clayton T. , Kim, Jin Hyoung , Kang, Byung Ju , Lee, Taehoon , Jegal, Yangjin , Won, Seung , Kim, Yangho , Ra, Seung Won

Mayo Clinic

Journal of Korean Medical Science | November 1, 2022 | Volume: 37 | Issue: 44 | Pages: No page available

10.3346/jkms.2022.37.e319 | PMID 36377294 Get It

Introduction. Evolution of radiation therapy techniques
Sahgal, Arjun , Sheehan, Jason P. , Niranjan, Ajay , Chambless, Lola B. , Ma, Lijun , Trifiletti, Daniel M.

Mayo Clinic

Neurosurgical Focus | November 1, 2022 | Volume: 53 | Issue: 5 | Pages: E1

10.3171/2022.8.focus22436 | PMID 36321287 Get It

Identification Accuracy of Safety‐Relevant Environmental Sounds in Adult Cochlear Implant Users
Luzum, Nathan , Hamel, Benjamin , Shafiro, Valeriy , Harris, Michael S. , Luzum, Nathan R , Hamel, Benjamin L , Harris, Michael S

Mayo Clinic

The Laryngoscope | November 1, 2022 | Volume: 133 | Issue: 9 | Pages: 2388-2393

10.1002/lary.30475 | PMID 36317721 Get It

Objective Examine cochlear implant (CI) users' ability to identify safety‐relevant environmental sounds, imperative for safety, independence, and personal well‐being. Methods Twenty‐one experienced adult CI users completed an Environmental Sound Identification (ESI) test consisting of 42 common environmental sounds, 28 of which were relevant to personal safety, along with 14 control sounds. Prior to sound identification, participants were shown sound names and asked to rate the familiarity and, separately, relevance to safety of each corresponding sound on a 1–5 scale. Results Overall ESI accuracy was 57% correct for the safety‐relevant sounds and 55% correct for control sounds. Participants rated safety‐relevant sounds as more important to safety and more familiar than the non‐safety sounds. ESI accuracy significantly correlated with familiarity ratings. Conclusion The present findings suggest mediocre ESI accuracy in postlingual adult CI users for safety‐relevant and other environmental sounds. Deficits in the identification of these sounds may put CI listeners at increased risk of accidents or injuries and may require a specific rehabilitation program to improve CI outcomes. Level of Evidence 4 Laryngoscope , 133:2388–2393, 2023
Spinal versus general anaesthesia in contemporary primary total knee arthroplasties
Owen, Aaron R. , Amundson, Adam W. , Duncan, Christopher M. , Smith, Hugh M. , Johnson, Rebecca L. , Taunton, Michael J. , Pagnano, Mark W. , Berry, Daniel J. , Larson, Dirk R. , Johnson, Rebecca L , Taunton, Michael J , Berry, Daniel J , Abdel, Matthew P.

Mayo Clinic

The Bone & Joint Journal | November 1, 2022 | Volume: 104-B | Issue: 11 | Pages: 1209-1214

10.1302/0301-620x.104b11.bjj-2022-0469.r2 | PMID 36317343 Get It

Aims Spinal anaesthesia has seen increased use in contemporary primary total knee arthroplasties (TKAs). However, controversy exists about the benefits of spinal in comparison to general anaesthesia in primary TKAs. This study aimed to investigate the pain control, length of stay (LOS), and complications associated with spinal versus general anaesthesia in primary TKAs from a single, high-volume academic centre. Methods We retrospectively identified 17,690 primary TKAs (13,297 patients) from 2001 to 2016 using our institutional total joint registry, where 52% had general anaesthesia and 48% had spinal anaesthesia. Baseline characteristics were similar between cohorts with a mean age of 68 years (SD 10), 58% female (n = 7,669), and mean BMI of 32 kg/m2 (SD 7). Pain was evaluated using oral morphine equivalents (OMEs) and numerical pain rating scale (NPRS) data. Complications including 30- and 90-day readmissions were studied. Data were analyzed using an inverse probability of treatment weighted model based on propensity score that included many patient and surgical factors. Mean follow-up was seven years (2 to 18). Results Patients treated with spinal anaesthesia required fewer postoperative OMEs (p < 0.001) and had lower NPRS scores (p < 0.001). Spinal anaesthesia also had fewer cases of altered mental status (AMS; odds ratio (OR) 1.3; p = 0.044), as well as 30-day (OR 1.4; p < 0.001) and 90-day readmissions (OR 1.5; p < 0.001). General anaesthesia was associated with increased risk of any revision (OR 1.2; p = 0.021) and any reoperation (1.3; p < 0.001). Conclusion In the largest single institutional report to date, we found that spinal anaesthesia was associated with significantly lower OME use, lower risk of AMS, and lower overall 30- and 90-day readmissions following primary TKAs. Additionally, spinal anaesthesia was associated with reduced risk of any revision and any reoperation after accounting for numerous patient and operative factors. When possible and safe, spinal anaesthesia should be considered in primary TKAs. Cite this article: Bone Joint J 2022;104-B(11):1209–1214.
Fluconazole Failure in the Treatment of Coccidioidal Meningitis
Ampel, Neil M. , Klanderman, Molly , Grill, Marie , Blair, Janis E. , Gupta, Simran , Klanderman, Molly , Grill, Marie F, Blair, Janis E

Mayo Clinic

Journal of Fungi | November 1, 2022 | Volume: 8 | Issue: 11 | Pages: 1157

10.3390/jof8111157 | PMID 36354924 Get It

Introduction: Coccidioidal meningitis (CM) is the most lethal form of disseminated coccidioidomycosis. Current guidelines recommend fluconazole as initial therapy but there has been a paucity of data regarding failure of fluconazole and optimal fluconazole dosage in the treatment of CM. We conducted this study to understand risk factors for fluconazole failure. Methods: We conducted a single-center retrospective chart review of patients diagnosed with coccidioidal meningitis between 1 January 1988 and 15 May 2021. Relevant demographic and clinical variables were collected, along with outcomes including treatment failure and death at any point. Univariate tests were conducted using the chi-squared goodness of fit test and analysis of variance. Results: Among 71 patients who began treatment for CM with fluconazole, 22 (31%) developed worsening meningitis at a median time of 206 days. Longer time from symptom onset to diagnosis of CM was a risk factor for fluconazole failure. Although the absolute failure rate of fluconazole starting dose of 400 mg daily was higher than that of 800 mg daily, the differences did not achieve statistical significance (p = 0.39). Conclusion: Fluconazole failure is not uncommon in the treatment of CM. A dose of 800 mg daily was not superior to a dose of 400 mg daily. All patients on fluconazole for CM require close monitoring.
Antineutrophil Cytoplasmic Autoantibodies–Associated Vasculitides and Risk of Stroke: A Systematic Review and Meta-analysis
Ungprasert, Patompong , Dejhansathit, Siroj , Cheungpasitporn, Wisit , Cheungpasitporn, Wisit , Wijarnpreecha, Karn

Mayo Clinic

Neurology India | November 1, 2022 | Volume: 70 | Issue: 5 | Pages: 1868-1873

10.4103/0028-3886.359250 | PMID 36352580 Get It

Background: Increased incidence of cardiovascular disease, including stroke, has been consistently observed in patients with chronic inflammatory diseases, although data on antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides (AAV) are still limited due to the relative rarity of the disease. Methods: Two investigators independently searched published studies indexed in MEDLINE and EMBASE database from inception to June 2019 using the search terms related to AAV and stroke. The eligible study must be cohort study that consisted of cohort of patients with AAV and cohort of patients without AAV. The study must follow the participants for incident stroke. The magnitude of difference in the incidence of stoke between the cohorts must be reported. Pooled effect estimates were calculated by combining the effect estimate of each eligible study using generic inverse variance method. Statistical heterogeneity was assessed using the Cochran's Q test and I 2 statistics. All analyses were conducted using RevMan 5.3 software from the Cochrane Collaboration. Results: A total of six cohort studies fulfilled the eligibility criteria and were included into the meta-analysis. Patients with AAV had a higher risk of developing incident stroke than individuals without AAV with the a pooled risk ratio of 2.02 (95% CI, 1.02–4.00; I 2 of 89%). Funnel revealed no suggestive evidence of publication bias. Conclusion: A significantly higher risk of incident stroke among patients with AAV than individuals without AAV was demonstrated by this meta-analysis.
Multi-modal fusion model for predicting adverse cardiovascular outcome post percutaneous coronary intervention
Bhattacharya, Amartya , Sadasivuni, Sudarsan , Chao, Chieh-Ju, Agasthi, Pradyumna , Holmes, David R. , Sanyal, Arindam , Banerjee, Imon , Banerjee, Imon , Chao, Chieh‐Ju , Arsanjani, Reza

Mayo Clinic

Physiological Measurement | November 1, 2022 | Volume: 43 | Issue: 12 | Pages: 124004

10.1088/1361-6579/ac9e8a | PMID 36317320 Get It

Abstract Background. Clinical medicine relies heavily on the synthesis of information and data from multiple sources. However, often simple feature concatenation is used as a strategy for developing a multimodal machine learning model in the cardiovascular domain, and thus the models are often limited by pre-selected features and moderate accuracy. Method. We proposed a two-branched joint fusion model for fusing the 12-lead electrocardiogram (ECG) signal data with clinical variables from the electronic medical record (EMR) in an end-to-end deep learning architecture. The model follows the joint fusion scheme and learns complementary information from ECG and EMR. Retrospective data from the Mayo Clinic Health Systems across four sites for patients that underwent percutaneous coronary intervention (PCI) were obtained. Model performance was assessed by area under the receiver-operating characteristics (AUROC) and Delong’s test. Results. The final cohort included 17,356 unique patients with a mean age of 67.2 ± 12.6 year (mean ± std) and 9,163 (52.7%) were male. The joint fusion model outperformed the ECG time-domain model with statistical margin. The model with clinical data obtained the highest AUROC for all-cause mortality (0.91 at 6 months) but the joint fusion model outperformed for cardiovascular outcomes - heart failure hospitalization and ischemic stroke with a significant margin (Delong’s p < 0.05). Conclusion. To the best of our knowledge, this is the first study that developed a deep learning model with joint fusion architecture for the prediction of post-PCI prognosis and outperformed machine learning models developed using traditional single-source features (clinical variables or ECG features). Adding ECG data with clinical variables did not improve prediction of all-cause mortality as may be expected, but the improved performance of related cardiac outcomes shows that the fusion of ECG generates additional value.
Multi-cancer early detection test sensitivity for cancers with and without current population-level screening options
Shao, Spencer H. , Clement, Jessica, Chung, Gina G., Gao, Jingjing , Hubbell, Earl , Liu, Minetta C. , Yimer, Habte, Tummala, Mohan K., Hubbell, Earl , Allen, Brian, Swanton, Charles , Tang, W.H. Wilson

Mayo Clinic

Tumori Journal | November 1, 2022 | Volume: 109 | Issue: 3 | Pages: 335-341

10.1177/03008916221133136 | PMID 36316952 Get It

There are four solid tumors with common screening options in the average-risk population aged 21 to 75 years (breast, cervical, colorectal, and, based on personalized risk assessment, prostate), but many cancers lack recommended population screening and are often detected at advanced stages when mortality is high. Blood-based multi-cancer early detection tests have the potential to improve cancer mortality through additional population screening. Reported here is a post-hoc analysis from the third Circulating Cell-free Genome Atlas substudy to examine multi-cancer early detection test performance in solid tumors with and without population screening recommendations and in hematologic malignancies. Participants with cancer in the third Circulating Cell-free Genome Atlas substudy analysis were split into three subgroups: solid screened tumors (breast, cervical, colorectal, prostate), solid unscreened tumors, and hematologic malignancies. In this post hoc analysis, sensitivity is reported for each subgroup across all ages and those aged ⩾50 years overall, by cancer, and by clinical cancer stage. Aggregate sensitivity in the solid screened, solid unscreened, and hematologic malignancy subgroups was 34%, 66%, and 55% across all cancer stages, respectively; restricting to participants aged ⩾50 years showed similar aggregate sensitivity. Aggregate sensitivity was 27%, 53%, and 60% across stages I to III, respectively. Within the solid unscreened subgroup, aggregate sensitivity was >75% in 8/18 cancers (44%) and >50% in 13/18 (72%). This multi-cancer early detection test detected cancer signals at high (>75%) sensitivity for multiple cancers without existing population screening recommendations, suggesting its potential to complement recommended screening programs. Clinical trial identifier: NCT02889978.
Time to cancer treatment and reproductive outcomes after fertility preservation among adolescent and young adult women with cancer
Meernik, Clare , Engel, Stephanie M. , Baggett, Christopher D. , Wardell, Ally, Zhou, Xi , Ruddy, Kathryn J. , Wantman, Ethan, Baker, Valerie L. , Mersereau, Jennifer E. , Smitherman, Andrew B. , Nichols, Hazel B. , Smitherman, Andrew B , Nichols, Hazel B , Wardell, Ally, Luke, Barbara , Cai, Jianwen , Olshan, Andrew F.

Mayo Clinic

Cancer | November 1, 2022 | Volume: 129 | Issue: 2 | Pages: 307-319

10.1002/cncr.34520 | PMID 36316813 Get It

AbstractBackgroundFertility preservation (FP) may be underused after cancer diagnosis because of uncertainty around delays to cancer treatment and subsequent reproductive success.MethodsWomen aged 15 to 39 years diagnosed with cancer between 2004 and 2015 were identified from the North Carolina Central Cancer Registry. Use of assisted reproductive technology (ART) after cancer diagnosis between 2004 and 2018 (including FP) was assessed through linkage to the Society for Assisted Reproductive Technology. Linear regression was used to examine time to cancer treatment among women who did (n = 95) or did not (n = 469) use FP. Modified Poisson regression was used to estimate risk ratios (RRs) and 95% CIs for pregnancy and birth based on timing of ART initiation relative to cancer treatment (n = 18 initiated before treatment for FP vs n = 26 initiated after treatment without FP).ResultsThe median time to cancer treatment was 9 to 33 days longer among women who used FP compared with women who did not, matched on clinical factors. Women who initiated ART before cancer treatment may be more likely to have a live birth given pregnancy compared with women who initiated ART after cancer treatment (age‐adjusted RR, 1.47; 95% CI, 0.98‐2.23), though this may be affected by the more frequent use of gestational carriers in the former group (47% vs 20% of transfer cycles, respectively).ConclusionsFP delayed gonadotoxic cancer treatment by up to 4.5 weeks, a delay that would not be expected to alter prognosis for many women. Further study of the use of gestational carriers in cancer populations is warranted to better understand its effect on reproductive outcomes.
Using New Hampshire Colonoscopy Registry data to assess United States and European post-polypectomy surveillance guidelines
Liu, Margaret C., Anderson, Joseph C. , Hisey, William , MacKenzie, Todd A. , Robinson, Christina M. , Butterly, Lynn F.

Mayo Clinic

Endoscopy | November 1, 2022 | Volume: 55 | Issue: 05 | Pages: 423-431

10.1055/a-1970-5377 | PMID 36316016 Get It

Background Our goal was to compare the updated European Society of Gastrointestinal Endoscopy (ESGE) and United States Multi-Society Task Force on Colorectal Cancer (USMSTF) high risk groups in predicting metachronous advanced neoplasia on first follow-up colonoscopy and long-term colorectal cancer (CRC). Methods We compared advanced metachronous neoplasia risk (serrated polyps ≥ 1 cm or with dysplasia, advanced adenomas [≥ 1 cm, villous, high grade dysplasia], CRC) on first surveillance colonoscopy in patients with high risk findings according to ESGE versus USMSTF guidelines. We also compared the positive and negative predictive values (PPV, NPV) of both guidelines for metachronous neoplasia. Results The risk for metachronous neoplasia in our sample (n = 20 458) was higher in the high risk USMSTF (3 year) (13.6 %; 95 %CI 12.3–14.9) and ESGE groups (13.6 %; 95 %CI 12.3–15.0) compared with the lowest risk USMSTF (5.1 %; 95 %CI 4.7–5.5; P < 0.001) and ESGE categories (6.3 %; 95 %CI 6.0–6.7; P < 0.001), respectively. Adding other groups such as USMSTF 5–10-year and 3–5-year groups to the 3-year category resulted in minimal change in the PPV and NPV for metachronous advanced neoplasia. High risk ESGE (hazard ratio [HR] 3.03, 95 %CI 1.97–4.65) and USMSTF (HR 3.07, 95 %CI 2.03–4.66) designations were associated with similar long-term CRC risk (CRC per 100 000 person-years: USMSTF 3-year group 3.54, 95 %CI 2.68–4.68; ESGE high risk group: 3.43, 95 %CI 2.57–4.59). Conclusion Performance characteristics for the ESGE and USMSTF recommendations are similar in predicting metachronous advanced neoplasia and long-term CRC. The addition of risk groups, such as the USMSTF 5–10-year and 3–5-year groups to the USMSTF 3-year category did not alter the PPV or NPV significantly.